Table 1.
Gene expression in hypothesized glioma subclasses.
Classical | Mesenchymal | Proneural | Neural |
---|---|---|---|
chr7 ↑/chr10 – (100%) | NF1 ↓ (53%) | PDGFRA ↑ | NEFL |
EGFR ↑ (97%) | NF1 ↓/PTEN ↓ (86%) | IDH1 | GABRA1 |
EGFRvIII (55%) | MET | TP53 +/− | SYT1 |
CDKN2A −/− | CHI3L1 | TP53 LOH | SLC12A5 |
NES ↑/Notch ↑ | CD44 ↑/MERTK ↑ | chr7 ↑/chr10 – (54%) | |
SHH signaling ↑ | NFκB signaling ↑ | OLIG2 ↑ (CDKN1A ↓) | |
SOX | |||
TCF4 |
The table shows changes in gene expression and LOH/deletions in genes in the four subclasses of glioma proposed by Verhaak et al. (9). The changes in gene expression that are characteristic of each subtype are highlighted in each column, and the percentage of cases that express these changes are present for the most ubiquitously expressed genes.